Clinical Trials Browser

INDUSTRY × Interventional × HER2 peptide (369-377) × Clear all

NCT02297698 2023-12-12

HER3+

Phase 2 Completed

100 enrolled 11 charts

Breast Neoplasms

NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Phase 2 Completed

275 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01479244 2017-02-27

PRESENT

Phase 3 Completed

Breast Neoplasms